​

Mineralys Therapeutics Ownership | Who Owns Mineralys Therapeutics?

OverviewForecastFinancialsChartTranscripts

Mineralys Therapeutics Ownership Summary

Mineralys Therapeutics is owned by 116.58% institutional investors, 1.47% insiders. Catalys pacific is the largest institutional shareholder, holding 13.60% of MLYS shares.

MLYS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMineralys Therapeutics116.58%1.47%-18.05%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Catalys pacific8.90M13.60%$337.63M
Ra capital management7.32M11.19%$277.72M
Samsara biocapital6.26M9.57%$237.50M
Blackrock funding, inc. /de3.67M5.61%$139.23M
Vanguard group3.02M4.61%$114.48M
Caligan partners lp2.77M4.24%$105.14M
Capital investors2.39M3.66%$90.76M
Suvretta capital management2.13M3.26%$80.85M
Sr one capital management, lp2.11M3.23%$80.16M
Fmr2.07M3.16%$78.54M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Catalys pacific8.90M96.09%$337.63M
Samsara biocapital6.26M31.01%$237.50M
Caligan partners lp2.77M13.77%$105.14M
Sr one capital management, lp2.11M11.59%$80.16M
Lion point capital, lp39.00K8.40%$1.48M
22nw, lp358.32K6.40%$13.59M
Velan capital investment management lp175.60K6.25%$6.66M
Integral health asset management1.50M3.85%$56.88M
Findell capital management250.00K3.74%$9.48M
Ra capital management7.32M3.42%$277.72M

Top Buyers

HolderShares% AssetsChange
Point72 asset management1.80M0.11%1.80M
Fmr2.07M0.00%1.77M
Farallon capital management1.67M0.26%1.67M
Holocene advisors, lp1.21M0.10%1.21M
Ra capital management7.32M3.42%1.18M

Top Sellers

HolderShares% AssetsChange
Tcg crossover management---2.47M
Integral health asset management1.50M3.85%-1.20M
Adams street partners---1.13M
Sr one capital management, lp2.11M11.59%-1.01M
Jennison associates376.35K0.01%-858.98K

New Positions

HolderShares% AssetsChangeValue
Point72 asset management1.80M0.11%1.80M$68.24M
Farallon capital management1.67M0.26%1.67M$63.44M
Holocene advisors, lp1.21M0.10%1.21M$45.71M
Polar capital1.06M0.19%1.06M$40.15M
Nearwater capital markets450.00K0.23%450.00K$17.06M

Sold Out

HolderChange
National bank of canada /fi/-7.00
Signaturefd-22.00
Skopos labs-26.00
Golden state wealth management-32.00
Ronald blue trust-56.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202519315.57%76,304,72316.16%1161.16%109-9.17%59118.52%
Jun 30, 20251663.75%65,673,2177.91%1000.77%1199.17%27-3.57%
Mar 31, 202515948.60%60,569,32731.79%1131.35%107-28-
Dec 31, 2024109-46,482,607-93-109---
Jun 30, 2024951.06%44,151,0375.44%891.03%6145.24%14-57.58%

Recent Insider Transactions

DateNameRoleActivityValue
Nov 20, 2025Slingsby Brian Taylor Sell$43.35M
Nov 11, 2025Levy Adam Scott CFO and SecretarySell$472.93K
Nov 11, 2025Levy Adam Scott CFO and SecretarySell$42.63K
Nov 11, 2025Levy Adam Scott CFO and SecretarySell$66.62K
Nov 11, 2025Levy Adam Scott CFO and SecretarySell$539.48K

Insider Transactions Trends

DateBuySell
2025 Q4-28
2025 Q3210
2025 Q2-9
2025 Q133
2024 Q4-4

MLYS Ownership FAQ

Who Owns Mineralys Therapeutics?

Mineralys Therapeutics shareholders are primarily institutional investors at 116.58%, followed by 1.47% insiders and -18.05% retail investors. The average institutional ownership in Mineralys Therapeutics's industry, Biotech Stocks , is 45.22%, which Mineralys Therapeutics exceeds.

Who owns the most shares of Mineralys Therapeutics?

Mineralys Therapeutics’s largest shareholders are Catalys pacific (8.9M shares, 13.60%), Ra capital management (7.32M shares, 11.19%), and Samsara biocapital (6.26M shares, 9.57%). Together, they hold 34.36% of Mineralys Therapeutics’s total shares outstanding.

Does Blackrock own Mineralys Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Mineralys Therapeutics.

Who is Mineralys Therapeutics’s biggest shareholder by percentage of total assets invested?

Catalys pacific is Mineralys Therapeutics’s biggest shareholder by percentage of total assets invested, with 96.09% of its assets in 8.9M Mineralys Therapeutics shares, valued at 337.63M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools